Filter Results:
(2,526)
Show Results For
- All HBS Web
(5,237)
- People (16)
- News (1,911)
- Research (2,526)
- Events (3)
- Multimedia (216)
- Faculty Publications (1,926)
Show Results For
- All HBS Web
(5,237)
- People (16)
- News (1,911)
- Research (2,526)
- Events (3)
- Multimedia (216)
- Faculty Publications (1,926)
Sort by
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
- 22 May 2007
- First Look
First Look: May 22, 2007
existing products as well as exploring into architectural and/or discontinuous innovation. Based on in-depth, longitudinal data on 13 business units and 22 innovations, we investigate the consequences of organization design choices on innovation View Details
Keywords: Martha Lagace
- 02 Jul 2015
- Op-Ed
The Future of the Greek Economy
ordinary citizens' income was cut by a third, vulnerable groups suffered. But more important, fifteen years later, the economy continues to decay, inflation is rampant, and many people continue to suffer. Whatever the outcome of the Greek... View Details
- 29 May 2018
- First Look
New Research and Ideas, May 29, 2018
312-032 Note on Bundled Payment in Health Care The note explains how bundled health care payment differs from fee-for-service payment, provides... View Details
Keywords: Dina Gerdeman
- 26 Jun 2012
- First Look
First Look: June 26
by a public health organization are randomly allocated to four groups. Agents in the control group receive a standard volunteer contract often offered for this type of task, whereas agents in the three treatment groups receive small... View Details
Keywords: Sean Silverthorne
- 21 Oct 2014
- First Look
First Look: October 21
Publisher's link: http://ukcatalogue.oup.com/product/9780198704072.do October 2014 Handbook of Conflict Management Research Reframing Hierarchical Interactions as Negotiations to Promote Change in Health View Details
Keywords: Sean Silverthorne
- 24 Sep 2013
- First Look
First Look: September 24
Abstract—Existing apology research has conceptualized apologies as a device to rebuild relationships following a transgression. As a result, apology research has failed to investigate the use of apologies for outcomes for which... View Details
Keywords: Sean Silverthorne
- 10 Oct 2007
- First Look
First Look: First Look: October 10
to customize therapy for individuals. However, adoption of this approach has progressed slowly and unevenly because the trial-and-error treatment model still governs how the health care system develops,... View Details
Keywords: Martha Lagace
- September 2010
- Teaching Note
Acumen Fund: Measurement in Impact Investing (TN) (A) and (B)
By: Alnoor Ebrahim
Teaching Note for 310011 and 310017. View Details
- 21 Apr 2020
- Research & Ideas
7 Successful Battle Strategies to Beat COVID-19
teams in territory that models cannot predict. COVID-19 events deliver surprises daily to many organizations, from health care specialists to government officials. The decision-making process that responds... View Details
Keywords: by Euvin Naidoo
- 28 Jan 2014
- First Look
First Look: January 28
After an overview of Boston Children's Hospital and its local health care market environment, the case presents process maps and financial data relating to patients making office visits to a plastic surgeon... View Details
Keywords: Sean Silverthorne
- 07 Apr 2011
- What Do You Think?
When Should the Public Sector Take Over in a Meltdown?
natural calamity, according to Kamal Gupta, the invitation is less important. Phil Clark, based on his experience, has concluded that "the sooner the government becomes involved in catastrophic events the better the outcome "... View Details
- 14 Nov 2019
- Book
Lifting the Lid on Turkey's Hidden Business History
in health and education, including founding Koç University in 1992, now one of the most prestigious universities in the country. Silverthorne: In what ways is Turkish business history distinctive and in what ways does it share... View Details
Keywords: by Sean Silverthorne
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
is likely to have a meaningful effect on health care spending patterns. In addition, precision medicines can change the expected profitability of therapies both by allowing more sophisticated pricing systems... View Details
Keywords: Carmen Nobel
- 02 Aug 2016
- First Look
August 2, 2016
Healthcare Partners Inc. (DaVita), in August 2013. The two would discuss whether Golomb should lead a new DaVita venture, Paladina Health (Paladina), which operated a network of primary care clinics. DaVita... View Details
Keywords: Sean Silverthorne
- 12 Mar 2019
- First Look
New Research and Ideas, March 12, 2019
available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55802 forthcoming Journal of Medical Economics Time-Driven Activity-Based Cost Analysis for Outpatient Anticoagulation Therapy: Direct Costs in a Primary Care... View Details
Keywords: Dina Gerdeman
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- 09 Jul 2018
- Research & Ideas
Overcoming the Challenges of Selling Brand New Technology (Hey, Need a 3-D Printer?)
Once a company grows large enough to scale, says Cespedes, it’s important that managers think strategically about segmenting its market, not just “partitioning” it into broad categories such as health care... View Details
- 06 Jun 2005
- Research & Ideas
Don’t Listen to “Yes”
meetings. In addition, since meetings have a start and finish time and are usually expected to be run very efficiently, everyone has probably experienced a "checklist" atmosphere. A: Leaders need to be careful about trying to... View Details
Keywords: by Martha Lagace
- 2024
- Working Paper
Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
This case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-133, July 2020. (Revised May 2024.)